Historical record - last NADAC effective date: 3/20/2019

Product Information

AMLODIPINE BESYLATE 2.5 MG TAB is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0160 per EA under NDC 76282023705. Its NADAC has been published 280 times since Nov 28, 2013.

FDA first approved this application on Aug 28, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE BESYLATE 2.5 MG TAB

Amlodipine besylate
$0.0160per EA

Strength

2.5 mg/1

NDC

76282023705

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

3/20/2019

Active Ingredients

AMLODIPINE BESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA077955

FDA Approved

8/28/2007

TE Code

AB

On Market Since

11/2/2007

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE BESYLATE 2.5 MG TAB has been published 280 times since Nov 28, 2013, and over the history we have for it it has declined 31.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0160 per EA
All-time high$0.0279 (Feb 12, 2014)
All-time low$0.0156 (Jun 20, 2018)
Median price$0.0203
Average price$0.0196
Largest weekly change+26.8% (Jan 22, 2014)
Weeks tracked280
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-31.0%

Last surveyed Apr 3, 2019 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE BESYLATE 2.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE BESYLATE 2.5 MG TAB, manufactured by Exelan Pharmaceuticals Inc., is $0.0160 per EA (NDC 76282023705), effective Apr 3, 2019.

How has the price of AMLODIPINE BESYLATE 2.5 MG TAB changed over time?

Over the history we have for it, the NADAC for AMLODIPINE BESYLATE 2.5 MG TAB has declined 31.0%. It has been tracked across 280 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for AMLODIPINE BESYLATE 2.5 MG TAB?

Since Nov 28, 2013, the NADAC for AMLODIPINE BESYLATE 2.5 MG TAB has ranged from a low of $0.0156 (Jun 20, 2018) to a high of $0.0279 (Feb 12, 2014), with a median of $0.0203 per EA.

Are there cheaper alternatives to AMLODIPINE BESYLATE 2.5 MG TAB?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE BESYLATE 2.5 MG TAB, is $0.0103 per EA — about 36% below AMLODIPINE BESYLATE 2.5 MG TAB.

Who manufactures AMLODIPINE BESYLATE 2.5 MG TAB?

AMLODIPINE BESYLATE 2.5 MG TAB (NDC 76282023705) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.